NovaBiotics Raises £5.0 million in a Private Placement from Woodford Investment Management

22-Jan-2015 - United Kingdom

High-throughput and high-sensitivity applications with Biacore 8 series 16 flow-cell SPR systems

Protection for Antibodies and Antigens Coated on Plates

Fast and accurate headspace gas analyzer for reliable quality control

NovaBiotics Ltd announces that Woodford Investment Management LLP has invested £5.0 million (gross) in a private placement.

The funds will provide working capital to enable NovaBiotics to achieve key value enhancing milestones in the short to mid-term. The priority for the business is driving forward the Company’s clinical stage, first-in-class antimicrobial therapeutics assets. NovaBiotics is also focused on further developing its earlier stage antifungal and antibacterial compounds and the anti-infective peptide platform from which these molecules have been derived.

The private placement with Woodford IM was arranged by Shore Capital as financial adviser and broker to the Company.

https://www.bionity.com/en/news/151281/novabiotics-raises-5-0-million-in-a-private-placement-from-woodford-investment-management.html

Topics

investments

Show all

Organizations

NovaBiotics

High-throughput screening of 1536 samples in just 27 seconds: The fastest microplate reader on the market

DNA-free PCR Reagents for Sensitive Analyses in Molecular Microbiology

The New Process Resin for the Purification of Large Biomolecules

Last viewed contents

To-BBB announces collaboration with Genzyme on brain delivery of biologics for neurodegenerative diseases

Go to page

VCU Massey Center researchers identify a new class of anti-cancer drugs based on platinum

Go to page

Kiadis Pharma announces collaboration with the Julius Maximilians University of Würzburg, Germany

Go to page

Echo Therapeutics Announces Positive Results of a Clinical Study of its Transdermal Continuous Glucose Monitoring System

Go to page

More from the department business & finance Subscribe to newsletter

Get the life science industry in your inbox

NovaBiotics Raises £5.0 million in a Private Placement from Woodford Investment Management

Qualifyze raises $12m to transform supply chain compliance in pharma by leveraging tech and audit data

Other news from the department business & finance

Merck Acquires JSR Chromatography Business

Novartis agrees to acquire Excellergy, Inc.

Growth in visitor numbers, full halls, clear future topics: analytica 2026 sets standards

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

Berlin names Health Innovation Quarter Berlin-Mitte the new place of the future

US pharmaceutical company Merck is acquiring Terns Pharmaceuticals for around $6.7 billion

Rentschler Biopharma completes the largest expansion in the company’s history in the US

Evonik shortens the path from research to market readinessEvonik launches Innovation Factory

VTU Engineering Germany gets new managing director

German analysis and laboratory industry cautiously optimistic about the current year

Automation and robotics drive growth in the laboratory

Roche launches AI initiative to tackle lengthy development times

Sartorius is counting on a biopharma boom by 2030

Biotech start-up secures €23 million total for cancer and infectious disease platform

German biotech company chooses Saxony-Anhalt for protein production facility

Nine million euros for innovative cancer therapy

Tecan aims to bring unused lab data to life with NVIDIA

Start-up AveThera acquires Fraunhofer site for biologics production

Chemicals still in trouble

​​​3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026

Get the life science industry in your inbox

Most read news

Start-up AveThera acquires Fraunhofer site for biologics production

BioNTech co-founders establish new biotech company

Plastic bottles turned into Parkinson’s medication

How old are we really?

More meat, lower risk of dementia: study reveals gene-dependent effect

Already approved drug is effective against aggressive brain tumors

Roche grows against the trend and invests over 700 million euros in Germany

Roche launches AI initiative to tackle lengthy development times

Failed experiment by Cambridge scientists leads to surprise drug development breakthrough

Disastrous interplay: protein uncovered that makes cancer grow faster

Vascular killer LDL cholesterol: are butter, eggs and cheese the culprits?

Vitamin B2 deficiency makes cancer cells more susceptible to programmed cell death

More news from our other portals

AI rebuilds molecules from exploding fragments

German food tech company secures €8 million to combat food waste

Non-destructive battery testing: New method developed

A flexible electrolyte for solid batteries

Amazonian cocoa could become a superfood

Chemical industry at a turning point: six keys to transformation

Why does oat milk sometimes foam perfectly and sometimes not at all?

WACKER cuts over 1,500 jobs to reduce costs by €300 million

How climate-friendly is insect protein really?

CO2 to E-Methanol, Aviation Fuels and Speciality Chemicals

How can startups revolutionize home cooking?

How a 270-year-old physics trick could supercharge affordable battery technology

Research team achieves breakthrough in breeding winter-hardy faba beans

BAM, HZB and HU are conducting joint research on sodium batteries

Tailor-made New Battery Materials

Energy storage breakthrough solves the fast-charging problem

How is refrigerator insulation turned back into high-quality MDI?

Last viewed contents

To-BBB announces collaboration with Genzyme on brain delivery of biologics for neurodegenerative diseases

VCU Massey Center researchers identify a new class of anti-cancer drugs based on platinum

Kiadis Pharma announces collaboration with the Julius Maximilians University of Würzburg, Germany

Echo Therapeutics Announces Positive Results of a Clinical Study of its Transdermal Continuous Glucose Monitoring System

3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026